Avalo Therapeutics, Inc. - Common Stock, $0.001 par value per share (AVTX)

Historical Holders from Q4 2023 to Q1 2025

Symbol
AVTX on Nasdaq
CUSIP
05338F306
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
10.4M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
7.53M
Holdings value
$56M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
33
Number of buys
15
Number of sells
-8
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Avalo Therapeutics, Inc. - Common Stock, $0.001 par value per share (AVTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOTECHNOLOGY VALUE FUND L P 9.99% $7.71M 1.04M BVF PARTNERS L P/IL Dec 31, 2024
Affinity Asset Advisors, LLC 5.3% $4.09M 551K Affinity Healthcare Fund, LP Dec 23, 2024

Institutional Holders of Avalo Therapeutics, Inc. - Common Stock, $0.001 par value per share (AVTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 1 $8.00 $8.00 1
2024 Q4 7.53M $56M +$4.83M $7.43 33
2024 Q3 6.66M $63.2M +$55.9M $9.50 28
2024 Q2 771K $9.62M +$7.42M $12.47 21
2024 Q1 701 $9.89K +$1.99K $21.74 4
2023 Q4 23K $209K +$209K $9.00 12